In The Media
Latest From The media
OCON Therapeutics Secures $10M in Funding to Revolutionize Women’s Health with Advanced Drug Delivery Solutions
June 24, 2024
|
Femtech Insider
OCON Therapeutics has been awarded the 2024 Seal of Excellence from the EU Commission – recognizing top-tier innovative ideas worthy of investment – for its IUB® Platform’s innovative nature and potential to drive meaningful change for women and families in the EU and globally.
April 3, 2024
|
EU Commission
OCON Therapeutics contributed to the World Economic Forum and McKinsey Health Institute’s report, “Closing the Women’s Health Gap: A $1 Trillion Opportunity to Improve Lives and Economies.”
January 17, 2024
|
World Economic Forum
OCON Therapeutics has reached its recruitment goal of its Phase IIb clinical study evaluating the revolutionary IUB® SEAD®, a non-invasive treatment for heavy menstrual bleeding affecting 1 in 3 women
March 24, 2023
